REGENECYTE cord blood cell therapy in post-COVID syndrome: a phase IIa randomized, placebo-controlled trial
Incidence rates of twelve chronic diseases/conditions in US adults: findings from a population-based study
SARS-CoV-2 infectious shedding and rebound among adults with and without oral antiviral use: two case-ascertained prospective household studies
Cross-binding antibodies capable of neutralising diverse hantaviruses are produced in response to Puumala virus infection
Methodological considerations in the attribution of long COVID to first or second infection – Authors' reply
Intramolecular loops control SARS-CoV-2 nucleocapsid protein self-association and nucleic acid binding dependent on phosphorylation
A Mammalian Surface Display Platform to Optimize the Antigenicity of Viral Proteins for Vaccine Design
A standardized atlas of human bronchoalveolar lavage cells built using scalable ensemble annotation and cross-study robust markers
Nanobodies against the S2 region of the spike protein potently neutralize SARS-CoV-2 viruses and show resistance to virus escape
A novel dual-chimeric surrogate virus to select, test and characterize mutants of protease and glycoprotein inhibitors.
Mechanism of SARS-CoV-2 resistance to nucleotide analog-based antivirals
SIMPLICITY is an agent-based, multi-scale mathematical model to study SARS-CoV-2 intra- and between-host evolution
Genomic epidemiology of SARS-CoV-2 in Peru from 2020 to 2024
Mechanism of SARS-CoV-2 resistance to nucleotide analog-based antivirals
SIMPLICITY is an agent-based, multi-scale mathematical model to study SARS-CoV-2 intra- and between-host evolution
Genomic epidemiology of SARS-CoV-2 in Peru from 2020 to 2024
Postholiday Flu Surge Hits Children Hard as Pediatric Cases Rise Nationwide
Chronic Respiratory Diseases Affect Nearly 570 Million People Worldwide, Study Finds
Las armas promovidas para la seguridad personal provocan una crisis de salud pública en comunidades negras
Inside the FDA’s Vaccine Uproar
Consejos contradictorios sobre las vacunas contra covid podrían afectar las tasas de vacunación, que ya son bajas
A Small Texas Think Tank Cultivated Covid Dissidents. Now They’re Running US Health Policy.
Moderna COVID vaccine 53% effective against adult hospitalization in 2024-25 season, data suggest
Economic hardship, adverse social conditions may put kids at higher risk for long COVID
US respiratory virus activity reaches high levels as flu, RSV spread